CFHR5 and deep vein thrombosis: We measured plasma CFHR5 concentration in a sample of 669 VTE patients from the MARseille Thrombosis Association Study (MARTHA) study that have been followed for VTE recurrence, among which 124 experienced a recurrent event (Supplementary data 2 [Tab_5])47.